German medical robotics start-up Reactive Robotics said earlier this month it raised a 7-figure funding amount as it looks to accelerate its platform development and entry into the global market.
The company is reportedly developing a robotic, intelligent therapy device designed to replace manual Very Early Mobilization therapy for use with intensive care patients.
Reactive Robotics said it has developed a prototype, as well as established quality management systems and inked cooperative deals with business partners and suppliers.
Existing investors include MTIP MedTech Innovation Partners AG, High-Tech Gründerfonds, Bayern Kapital and TQ-Group, according to a press release.
Reactive Robotics said it expects to deliver its 1st clinical test product by the 1st quarter of 2018.
